The NIH has selected OMRF to lead a $58.5 million public-private partnership aimed at developing more effective treatments for autoimmune diseases.
The federal grants will support the work of two OMRF scientists who are investigating different aspects of autoimmune disease: Judith James, M.D., Ph.D., and Joan Merrill, M.D.
Joan Merrill, M.D., is a recipient of the 2018 ACR Master designation, one of the highest honors members can receive.
The goal of the new white paper is to create a dramatic shift in how lupus clinical trials are conducted so effective treatments can stand a chance to succeed.
The grants cover a range of areas, including colitis and colon cancer, sepsis, genomic tools, and outreach strategies for clinical trials.
These findings will help scientists understand how to better diagnose and treat the disease.